These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29054497)

  • 21. Male pattern baldness is not associated with established cardiovascular risk factors in the general population.
    Ellis JA; Stebbing M; Harrap SB
    Clin Sci (Lond); 2001 Apr; 100(4):401-4. PubMed ID: 11256978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Family history of cancer and the risk of prostate cancer and benign prostatic hyperplasia.
    Negri E; Pelucchi C; Talamini R; Montella M; Gallus S; Bosetti C; Franceschi S; La Vecchia C
    Int J Cancer; 2005 Apr; 114(4):648-52. PubMed ID: 15578689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgenetic alopecia as an early marker of benign prostatic hyperplasia.
    Arias-Santiago S; Arrabal-Polo MA; Buendía-Eisman A; Arrabal-Martín M; Gutiérrez-Salmerón MT; Girón-Prieto MS; Jimenez-Pacheco A; Calonje JE; Naranjo-Sintes R; Zuluaga-Gomez A; Serrano Ortega S
    J Am Acad Dermatol; 2012 Mar; 66(3):401-8. PubMed ID: 21835498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic association between PSA-158G/A polymorphism and the susceptibility of benign prostatic hyperplasia: a meta-analysis.
    Su XJ; Zeng XT; Fang C; Liu TZ; Wang XH
    Oncotarget; 2017 May; 8(20):33953-33960. PubMed ID: 28430620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole blood selenium levels (WBSL) in patients with prostate cancer (PC), benign prostatic hyperplasia (BPH) and healthy male inhabitants (HMI) and prostatic tissue selenium levels (PTSL) in patients with PC and BPH.
    Muecke R; Klotz T; Giedl J; Buentzel J; Kundt G; Kisters K; Prott FJ; Micke O
    Acta Oncol; 2009; 48(3):452-6. PubMed ID: 18855158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age-dependent associations between androgenetic alopecia and prostate cancer risk.
    Muller DC; Giles GG; Sinclair R; Hopper JL; English DR; Severi G
    Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):209-15. PubMed ID: 23074289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.
    van Vuuren SP; Heyns CF; Zarrabi AD
    BJU Int; 2012 Apr; 109(8):1194-7. PubMed ID: 21851551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect.
    Habuchi T; Liqing Z; Suzuki T; Sasaki R; Tsuchiya N; Tachiki H; Shimoda N; Satoh S; Sato K; Kakehi Y; Kamoto T; Ogawa O; Kato T
    Cancer Res; 2000 Oct; 60(20):5710-3. PubMed ID: 11059764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention.
    Edlin RS; Heyns CF; Van Vuuren SP; Zarrabi AD
    S Afr J Surg; 2012 Nov; 50(4):127-30. PubMed ID: 23217554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of elevated interleukin-17 and angiopoietin-2 with prostate size in benign prostatic hyperplasia.
    Arivazhagan J; Nandeesha H; Dorairajan LN; Sreenivasulu K
    Aging Male; 2017 Jun; 20(2):115-118. PubMed ID: 28590830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Male pattern baldness and the risk of prostate cancer.
    Yassa M; Saliou M; De Rycke Y; Hemery C; Henni M; Bachaud JM; Thiounn N; Cosset JM; Giraud P
    Ann Oncol; 2011 Aug; 22(8):1824-7. PubMed ID: 21324955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case-control study of baldness in relation to myocardial infarction in men.
    Lesko SM; Rosenberg L; Shapiro S
    JAMA; 1993 Feb; 269(8):998-1003. PubMed ID: 8429606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative studies on level of androgens in hair and plasma with premature male-pattern baldness.
    Bang HJ; Yang YJ; Lho DS; Lee WY; Sim WY; Chung BC
    J Dermatol Sci; 2004 Feb; 34(1):11-6. PubMed ID: 14757277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostate inflammation. Association with benign prostatic hyperplasia and prostate cancer.
    Abdel-Meguid TA; Mosli HA; Al-Maghrabi JA
    Saudi Med J; 2009 Dec; 30(12):1563-7. PubMed ID: 19936421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between Prostatitis, Benign Prostatic Hyperplasia and Prostate Cancer: A systematic review and Meta-analysis.
    Zhang L; Wang Y; Qin Z; Gao X; Xing Q; Li R; Wang W; Song N; Zhang W
    J Cancer; 2020; 11(1):177-189. PubMed ID: 31892984
    [No Abstract]   [Full Text] [Related]  

  • 37. Preventive effects of Monascus on androgen-related diseases: androgenetic alopecia, benign prostatic hyperplasia, and prostate cancer.
    Chiu HW; Chen MH; Fang WH; Hung CM; Chen YL; Wu MD; Yuan GF; Wu MJ; Wang YJ
    J Agric Food Chem; 2013 May; 61(18):4379-86. PubMed ID: 23651036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ; Baxter RC
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):333-42. PubMed ID: 9156044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate carcinoma risk subsequent to diagnosis of benign prostatic hyperplasia: a population-based cohort study in Sweden.
    Chokkalingam AP; Nyrén O; Johansson JE; Gridley G; McLaughlin JK; Adami HO; Hsing AW
    Cancer; 2003 Oct; 98(8):1727-34. PubMed ID: 14534890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alopecia and its association with coronary heart disease and cardiovascular risk factors: a meta-analysis.
    Trieu N; Eslick GD
    Int J Cardiol; 2014 Oct; 176(3):687-95. PubMed ID: 25150481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.